by Sam Eskandari | May 15, 2019 | News
VANCOUVER, British Columbia, May 15, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has undertaken steps to restructure and rebuild Cannevert Therapeutics Ltd. (“CTL”), a wholly owned...
by Sam Eskandari | May 15, 2019 | News
SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce the completion of its clinical trial on its lead cannabis...
by Sam Eskandari | Mar 4, 2019 | News
VANCOUVER, British Columbia, March 04, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has filed a claim and is commencing legal proceedings against Liht Cannabis Corp. (“Liht”)...
by Sam Eskandari | Feb 22, 2019 | News
SAN JUAN, Puerto Rico, Feb. 22, 2019 — Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), today announced the dosing of the first adult volunteer in its clinical trial of...
by Sam Eskandari | Feb 12, 2019 | News
VANCOUVER, British Columbia, Feb. 12, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into an agreement with TG Initiatives Ltd., to purchase a commercial processing...
by Sam Eskandari | Feb 11, 2019 | News
SAN JUAN, Puerto Rico, Feb. 11, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), in partnership with the Institute for Medical Cannabis (“IMC”) and the Fundación de...
